Castle Hill Hospital is an NHS hospital to the west of Cottingham, East Riding of Yorkshire, England, and is run by Hull University Teaching Hospitals NHS Trust.

During the past decade, Castle Hill Hospital conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 4 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 2 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Castle Hill Hospital" #1 sponsor was "University College, London" with 7 trials, followed by "Hull University Teaching Hospitals NHS Trust" with 4 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored, "NHS Greater Glasgow and Clyde" with 2 trials sponsored and "Queen Mary University of London" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Castle Hill Hospital" #1 collaborator was "Cancer Research UK" with 9 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Takeda" with 3 trials as a collaborator, "University of Glasgow" with 2 trials as a collaborator and "Australasian Leukaemia and Lymphoma Group" with 1 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Castle Hill Hospital" are "Heart Failure" (4 trials), "Breast Cancer" (2 trials), "Multiple Myeloma" (2 trials), "Oesophageal Cancer" (2 trials) and "Prostate Cancer" (2 trials). Many other conditions were trialed in "Castle Hill Hospital" in a lesser frequency.

Most popular intervention types in "Castle Hill Hospital" are "Drug" (27 trials), "Other" (4 trials), "Procedure" (4 trials), "Device" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Degarelix" (2 trials) and "Paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Castle Hill Hospital" are 33 trials for "All" genders, 4 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Castle Hill Hospital". undefined are not yet recruiting, 9 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Castle Hill Hospital, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Castle Hill Hospital, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 8 trials that are defined as “Not Applicable".